LIPO同业对比
LIPO 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIPO本股 | $11M#7 | — | 7.1x#11 | 19.8x#3 | 19.3%#3 | -8.6%#5 | -947.2%#1 | -337.2%#9 | — | — | — | — |
| AEON | $13M#2 | — | — | — | — | -193.4%#10 | — | — | — | — | — | — |
| ASBP | $12M#3 | 0.0x#3 | 1.0x#5 | 1920.0x#4 | — | -1768.9%#13 | -312016.9%#4 | -208.2%#6 | — | — | — | — |
| PHIO | $12M#4 | — | 0.9x#4 | — | -100.0%#4 | -21.7%#6 | — | -69.0%#3 | — | — | — | — |
| KPRX | $12M#5 | — | 0.7x#3 | — | -100.0%#4 | -401.4%#12 | — | -0.1%#1 | -127.6%#3 | — | — | — |
| DARE | $11M#6 | — | — | 10.9x#2 | 10429.4%#1 | -230.9%#11 | -1315.5%#2 | — | — | — | — | — |
| BPTH | $11M#8 | — | — | — | -100.0%#4 | 38.5%#2 | — | — | — | — | — | — |
| MTVA | $10M#9 | — | 1.5x#8 | — | — | 53.0%#1 | — | -190.2%#5 | — | — | — | — |
| TOVX | $10M#10 | 0.2x#4 | 0.2x#1 | — | -100.0%#4 | 7.5%#4 | — | -42.1%#2 | -51.4%#1 | — | — | — |
| PPCB | $37M#1 | 0.0x#1 | 3.7x#10 | — | — | -3136.6%#14 | — | -599.6%#11 | -533.3%#4 | — | — | — |
| KALA | $10M#12 | 0.0x#2 | 1.1x#6 | — | — | 29.9%#3 | — | -298.3%#8 | -69.9%#2 | — | — | — |
| AZTR | $10M#13 | 8.1x#6 | 1.3x#7 | — | -100.0%#4 | -22.2%#7 | — | -149.4%#4 | — | — | — | — |
| FBLG | $10M#14 | 0.5x#5 | 2.1x#9 | — | — | -67.1%#9 | — | -402.2%#10 | -1409.7%#6 | — | -86.2%#1 | — |
| VTGN | $10M#11 | — | 0.4x#2 | 8.0x#1 | 161.1%#2 | -35.5%#8 | -5683.7%#3 | -284.7%#7 | -949.7%#5 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议